Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
21.62B | 22.54B | 22.77B | 23.59B | 24.79B | 24.66B | Gross Profit |
5.47B | 6.25B | 5.72B | 5.30B | 5.04B | 4.86B | EBIT |
781.00M | 1.38B | 1.13B | 993.00M | 819.00M | 802.00M | EBITDA |
1.76B | 2.29B | 1.92B | 1.80B | 1.65B | 1.58B | Net Income Common Stockholders |
871.00M | 1.15B | 895.00M | 748.00M | 602.00M | 736.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.43B | 5.92B | 10.35B | 8.43B | 7.40B | 8.72B | Total Assets |
22.81B | 25.56B | 24.24B | 22.81B | 22.29B | 22.82B | Total Debt |
660.00M | 923.00M | 532.00M | 660.00M | 874.00M | 1.36B | Net Debt |
-7.77B | -2.78B | -9.82B | -7.77B | -6.53B | -7.36B | Total Liabilities |
4.98B | 5.69B | 5.06B | 4.98B | 4.95B | 6.01B | Stockholders Equity |
17.83B | 19.87B | 19.18B | 17.83B | 17.34B | 16.81B |
Cash Flow | Free Cash Flow | ||||
0.00 | -415.00M | 2.42B | 1.53B | -694.00M | 369.00M | Operating Cash Flow |
0.00 | 359.00M | 2.97B | 1.74B | -187.00M | 725.00M | Investing Cash Flow |
0.00 | -6.42B | -527.00M | -201.00M | -561.00M | 245.00M | Financing Cash Flow |
0.00 | -590.00M | -523.00M | -518.00M | -569.00M | -563.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥16.00B | 12.95 | 3.61% | 1.83% | 19.05% | ||
76 Outperform | ¥14.60B | 17.00 | 1.25% | 6.22% | 29.99% | ||
70 Outperform | ¥15.90B | 13.89 | 2.46% | -1.02% | 27.93% | ||
70 Neutral | ¥16.77B | 151.52 | 2.13% | 4.02% | -87.61% | ||
69 Neutral | ¥12.97B | 12.67 | 5.01% | 4.11% | -5.13% | ||
62 Neutral | $11.90B | 10.64 | -7.50% | 2.90% | 7.41% | -8.19% |